Analysis of new N-category on prognosis of oesophageal cancer with positive lymph nodes in a Chinese population

1. Mei G, Yi-dian Z, Hai-jun Y. Analysis of clinicopathological characteristics for 5406 cases of esophageal neoplasm. Chin J Cancer Prev Treat 2008; 15: 54-6.Search in Google Scholar

2. Debevec L, Jeric T, Kovac V, Bitenc M, Sok M. Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006. Radiol Oncol 2009; 43: 47-53.10.2478/v10019-009-0008-xSearch in Google Scholar

3. Kovac V, Zwitter M, Zagar T. Population-based survey of malignant pleural mesothelioma in Slovenia: improved survival after introduction of chemotherapy. Radiol Oncol 2012; 46(2): 136-44.10.2478/v10019-012-0032-0347293823077450Search in Google Scholar

4. Lerut TE, de Leyn P, Coosemans W, Van Raemdonck D, Cuypers P, Van Cleynenbreughel B. Advanced esophageal carcinoma. World J Surg 1994; 18: 379-87.10.1007/BF003168188091779Search in Google Scholar

5. Waterman TA, Hagen JA, Peters JH, DeMeester SR, Taylor CR, Demeester TR. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg 2004; 78: 1161-9.10.1016/j.athoracsur.2004.04.04515464464Search in Google Scholar

6. Rice TW, Rusch VW, Ishwaran H, Blackstone EH; Worldwide Esophageal Cancer Collaboration. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals. Cancer 2010; 116: 3763-73.10.1002/cncr.2514620564099Search in Google Scholar

7. Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006; 132: 1374-81.10.1016/j.jtcvs.2006.07.03917140960Search in Google Scholar

8. Hsu WH, Hsu P K, Hsieh CC, Huang CS, Wu YC. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg 2009; 13: 1913-20.10.1007/s11605-009-0982-819672664Search in Google Scholar

9. Zhang HL, Chen LQ, Liu RL, Shi YT, He M, Meng XL, et al. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma. Dis Esophagus 2010; 23: 53-8.10.1111/j.1442-2050.2009.00971.x19392846Search in Google Scholar

10. Liu YP, Ma L, Wang SJ, Chen YN, Wu GX, Han M, et al. Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma. Eur J Surg Oncol 2009; 36: 155-9.10.1016/j.ejso.2009.09.00519854606Search in Google Scholar

11. Kelty CJ, Kennedy CW, Falk GL. Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. J Thorac Oncol 2010; 5: 1467-71.10.1097/JTO.0b013e3181e8f6b120812404Search in Google Scholar

12. Bollschweiler E, Schröder W, Hölscher AH, Siewert JR. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 2000; 87: 1106-10.10.1046/j.1365-2168.2000.01474.xSearch in Google Scholar

13. Mariette C, Finzi L, Piessen G, Van Seuningen I, Triboulet JP. Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg 2005; 29: 39-45.10.1007/s00268-004-7542-xSearch in Google Scholar

14. Xu Q, Zhuge X, Zhang H, Ping Y, Chen L. The N-Classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis? World J Surg 2011; 35: 1303-10.Search in Google Scholar

15. Bystricky B, Okines AF, Cunningham D. Optimal therapeutic strategies for resecTable oesophageal or oesophagogastric junction cancer. Drugs 2011; 71: 541-55.10.2165/11585460-000000000-00000Search in Google Scholar

16. Schreiber D, Rineer J, Vongtama D, Wortham A, Han P, Schwartz D, et al. Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol 2010; 5: 244-50.10.1097/JTO.0b013e3181c5e34fSearch in Google Scholar

17. Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003; 75: 331-6.10.1016/S0003-4975(02)04401-6Search in Google Scholar

18. Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, Ide H, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997; 114: 205-9.10.1016/S0022-5223(97)70146-6Search in Google Scholar

19. Pouliquen X, Levard H, Hay JM, McGee K, Fingerhut A, Langlois-Zantin O. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for surgical research. Ann Surg 1996; 223: 127-33.10.1097/00000658-199602000-0000312350878597505Search in Google Scholar

20. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003; 21: 4592-6.10.1200/JCO.2003.12.09514673047Search in Google Scholar

21. Chen J, Zhu J, Pan J, Zhu K, Zheng X, Chen M, Wang J, Liao Z. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus. Ann Thorac Surg 2010; 90: 435-42.10.1016/j.athoracsur.2010.04.00220667325Search in Google Scholar

22. Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GM, Murthy SC, et al. Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol 2009; 4: 1264-9.10.1097/JTO.0b013e3181b26f8e19668013Search in Google Scholar